Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor

Journal of Clinical Virology

Volumn 36, Issue 3, 2006, Pages 231-234

  Almeida, Robério P A ^a,b   Cardoso, Divina D D P ^a  

^a Inst de Patol Trop e Saude Pub   (Brazil)

^b Central Goiana de Sorologia Imuno hematologia e Biologia Molecular   (Brazil)

Author keywords

Blood donor; HBsAg; HBV DNA; Nested PCR

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; CASE REPORT; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FEMALE; HEPATITIS B VIRUS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; SEROLOGY; TRANSFUSION; VIRUS CORE; VIRUS DETECTION; VIRUS GENOME; VIRUS TRANSMISSION;

EID: 33745063904     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.02.004     Document Type: Article

References (24)

1. Allain J.P. Occult hepatitis B vírus infection. Transfusion 11 1 (2004) 18-25
2. Badur S., and Akgun A. Diagnosis of hepatitis B virus and monitoring of treatment. J Clin Virol 21 (2001) 229-237
3. Biswas R., Tabor E., Hsia C.C., Wright D.J., Laycock M.E., and Fiebig E.W. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43 (2003) 788-798
4. Bodhiphala P., Chiewssilp P., Chaturachumroenchai S., and Pruksananonda P. Detection of HBV genome by gene amplification method in HBsAg negative blood donors. J Med Assoc Thai 5 82 (1999) 491-495
5. Bréchot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., and Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely. Hepatology 34 1 (2001) 194-203
6. Chemin I., Zoulim F., Merle P., Arkhins A., Chevallier M., Kay A., et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 34 (2001) 447-454
7. Grethe S., Monazahian M., Bohme I., and Thomssen R. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 72 9 (1998) 7692-7696
8. Hino K., Basuni A.A., Ireland J., Newell A., Mphahlele J., Smit E.J., et al. Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation?. Dig Dis Scien 2 47 (2002) 415-418
9. Huo T., Wu J.-C., Lee P.-C., Chau G.-C., Lui W.-Y., Tsay S.-H., et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 8 (1998) 231-236
10. Jongerius J.M., Cuypers H.T.M.C., van Oostendorp W.R., Lelie P.N., van der Poel C.L., and Leeuwen E.F. New hepatitis B virus mutant form in a blood donor that in undetectable in several hepatitis B surface antigen screening assays. Transfusion 38 (1998) 56-59
11. Korelitz J.J., Busch M.P., and Kleinman S.H. A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion 37 (1997) 634-640
12. Lai M.E., Farci P., Figus A., Balestrieri A., Arnone M., and Vyas G.N. Hepatitis B virus DNA in the serum of sardiniam blood donors negative for the hepatitis B surface antigen. Blood 73 1 (1989) 17-19
13. Laperche S., Guitton C., Smilovici W., and Courouce A.M. Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen. Vox Sanguinis 80 (2001) 90-94
14. Larsen J., Hetland G., and Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 30 5 (1990) 431-432
15. Pereira A. Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union. Transfusion 43 (2003) 192-201
16. Prince A.M., Lee D.-H., and Brotman B. Infectivity of blood from PCR-positive, HBsAg negative, anti-HBs positive cases of resolved hepatitis B infection. Transfusion 41 (2001) 329-332
17. Roth W.K., Weber M., Petersen D., Drosten C., Buhr S., Sireis W., et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 42 (2002) 869-875
18. Saito T., Shinzawa H., and Uchida T. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis. J Med Virol 58 (1999) 325-331
19. Schreiber G.B., Busch M.P., Kleinman S.H., and Korelitz J.J. The risk of transfusion-transmitted viral infections. N Engl J Med 334 (1996) 1685-1690
20. Shih L.N., Sheu J.C., Wang J.T., Huang G.T., Yang P.M., Lee H.S., et al. Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J Med Virol 32 4 (1990) 257-260
21. Wang J.T., Wang T.H., Lee C.-Z., Chen P.-J., Wang T.-H., and Chen D.-S. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 42 (2002) 1592-1597
22. Wang J.T., Wang T.H., Sheu J.C., Shih L.N., Lin J.T., and Chen D.S. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 163 2 (1991) 397-399
23. Weinberger K.M., Bauer T., Bohn S., and Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81 (2000) 1165-1174
24. Zervou E.K., Dalekos G.N., Boumba D.S., and Tsianos E.V. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-years prospective study in Northwestern Greece. Transfusion 41 (2001) 652-658